CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for INVO BioScience Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

INVO BioScience Inc
5582 Broadcast Ct
Phone: (978) 878-9505p:978 878-9505 LAKEWOOD RANCH, FL  34240-8471  United States Ticker: IVOBIVOB

Business Summary
INVO Bioscience, Inc. is a medical device company. The Company is focused on creating various treatments for patients diagnosed with infertility. The Company's product, the INVOcell, is a medical device used in infertility treatment and is considered as an assisted reproductive technology (ART). INVOcell is an intravaginal culture (IVC) system used for preparing, holding and transferring human gametes or embryos during vaginal in vitro fertilization or intravaginal culture procedures (IVF/IVC). The INVOcell system consists of various components: INVOcell Culture Device, INVOcell Retention Device and INVOcell Holding Block. The INVO Procedure is a fertility treatment option allowing fertilization and early embryo development to take place inside the woman's body. The INVO Procedure is an IVC or in vivo incubation assisted reproduction technique available.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201912/31/2018YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Kathleen T.Karloff 62 10/10/2019 12/5/2008
Chief Executive Officer, Director Steven M.Shum 49 10/10/2019 10/11/2017
Chief Financial Officer Debra R.Hoopes 51 8/14/2019 8/14/2019
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Bio X Cell, Inc.
IVOB

General Information
Number of Employees: 2 (As of 12/31/2018)
Outstanding Shares: 155,596,112 (As of 9/30/2019)
Shareholders: 101
Stock Exchange: OTC
Federal Tax Id: 204036208


Copyright © 2020 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 23, 2020